Selection of an Efficient AAV Vector for Robust CNS Transgene Expression

Hanlon, Killian S., Meltzer, Jonah C., Buzhdygan, Tetyana, Cheng, Ming J., Sena-Esteves, Miguel, Bennett, Rachel E., Sullivan, Timothy P., Razmpour, Roshanak, Gong, Yi, Ng, Carrie, Nammour, Josette, Maiz, Daniela, Dujardin, Simon, Ramirez, Servio H., Hudry, Eloise, Maguire, Casey A.·2019·Molecular Therapy - Methods & Clinical Development
DOI 10.1016/j.omtm.2019.10.007

Cited by (148)

Items 101–148 of 148

  1. Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia
    Francis J. May, PamelaSara E. Head, Leah E. Venturoni, Randy J. Chandler, Charles P. Venditti · 2021 · Molecular Therapy — Methods & Clinical Development
  2. Viral vectors for gene delivery to the central nervous system
    Selene Ingusci, Bonnie L. Hall, William F. Goins, Justus B. Cohen, Joseph C. Glorioso · 2024 · Handbook of clinical neurology
  3. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy
    Umut Cagin · 2021 · Advances in experimental medicine and biology
  4. Functional analysis of mutations endowing rAAV2-retro with retrograde tracing capacity
    Yujing Zhang, Jingyi Wang, Jiamin Li, Yefei Chen, Jing Sun, Zhonghua Lu, Yuantao Li, Taian Liu · 2022 · Neuroscience Letters
  5. Virus-Based Neural Circuit Tracing
    Fuqiang Xu, Qing Lin Liu · 2024 · Advances in neurobiology
  6. Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier
    Yizheng Yao, Fengfeng Bei · 2024 · Advances in neurobiology
  7. Parent-map: analysis of parental contributions to evolved or engineered protein or DNA sequences
    Damien Marsic · 2021 · The Journal of Open Source Software
  8. Recent developments in gene therapy research in India
    Ruchita Selot, Arkasubhra Ghosh · 2024 · Journal of Biosciences
  9. Crossing the Blood-Brain Barrier with AAVs: What’s After SMA?
    Yujia A. Chan, Benjamin E. Deverman · 2022 · AAPS advances in the pharmaceutical sciences series
  10. Engineered AAVs for Non-Invasive Functional Transgene Expression in Rodent and Non-Human Primate Central and Peripheral Nervous Systems
    Xinhong Chen, Sripriya Ravindra Kumar, Cameron D. Adams, Daping Yang, Tongtong Wang, Cynthia Mary Arokiaraj, Damien A. Wolfe, Victoria Ngo, Lillian Campos, Jessica A. Griffiths et al. · 2022 · SSRN Electronic Journal
  11. In vivo Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base Editor
    Christiano R. R. Alves, Sabyasachi Das, Vijai Krishnan, Leillani L. Ha, Lauren R. Fox, Hannah E. Stutzman, Claire E. Shamber, Pazhanichamy Kalailingam, Siobhan McCarthy, Christian Lacks Lino Cardenas et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Engineered CRISPR-Base Editors as a Permanent Treatment for Familial Dysautonomia
    Shuqi Yun, Anil K. Chekuri, Jennifer Art, Krishnakanth Kondabolu, Samikshya Pokharel, Paolo Pigini, Sydnee Dymock, David Rufino-Ramos, Susan A. Slaugenhaupt, Nadja Zeltner et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  13. AAV delivery of RNA editing machinery rescues SUDEP and seizure phenotype in a mouse model of Dravet Syndrome
    Ellie M. Chilcott, Juan F. Antinao Diaz, Amanda Almacellas‐Barbanoj, Marc Moore, Anna Keegan, Zakary Waddington, Vicky Fang, Stéphanie Schorge, Gabriele Lignani, Simon N. Waddington et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerve
    Edwina Abou Haidar, Shilpa Prabhakar, Pike-See Cheah, Killian S. Hanlon, Paula Espinoza, Adam V. Crain, Nikita Patel, Greta W. Radcliff, Ming Liang Cheng, Iván Coto Hernández et al. · 2025 · Gene Therapy
  15. Understanding the Crossing of Blood–Brain Barrier Using Nanocarriers: Current Trends and the Role of Physiologically Based Pharmacokinetic Modeling
    Abdul Azeez Nazeer, Sung‐Hoon Ahn · 2025 · IEEE Transactions on NanoBioscience
  16. Blood–brain barrier-penetrant AAV vectors for cell type-specific gene expression in the mouse brain
    Hirokazu Hirai, Shu Iwazaki, Reona Hoshino, Tokuzo Maruyama, Ryo Aoki, Putri T. Radhiyanti, Ayumu Konno · 2025 · Anatomical Science International
  17. The Roads We Take: Cellular Targets and Pathways Leading Biologics Across the Blood–Brain Barrier
    Habib Baghirov · 2022 · Frontiers in Drug Delivery
  18. Directed Evolution of AAV9 for Efficient Gene Expression in Cardiomyocytes In Vitro and In Vivo
    Leonard Hüttermann, Lena C. Schröder, Prithviraj Manohar Vijaya Shetty, Timo Jonker, Susanne S. Hille, Anca Kliesow Remes, Andrea Matzen, Arnie Boender, Dirk Grimm, Derk Frank et al. · 2025 · Human Gene Therapy
  19. Considerations When Developing Blood–Brain Barrier Crossing Drug Delivery Technology
    Robert D. Bell · 2021 · Handbook of experimental pharmacology
  20. Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
    Kleopatra Rapti, Olena Maiakovska, Jonas Becker, Joanna Szumska, Margarita Zayas, Felix Bubeck, Jixin Liu, Emma Gerstmann, Chiara Krämer, Ellen Wiedtke et al. · 2022 · Journal of Visualized Experiments
  21. In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord
    Killian S. Hanlon, Ming Liang Cheng, Demitri de la Cruz, Nikita J. Patel, Miguel C. Santoscoy, Yi Gong, Carrie Ng, Diane M. Nguyen, Josette Nammour, Sean W. Clark et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in mice
    Miguel C. Santoscoy, Paula Espinoza, Killian S. Hanlon, Luna Yang, Lisa Nieland, Carrie Ng, Christian E. Badr, Suzanne E. Hickman, Demitri de la Cruz, Ana Griciuc et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina
    Youssef Fouani, Dragica Blazevic, Martin Oti, Robert Becker, Benjamin Strobel, Tanja Schönberger, Marius Stephan, Sven Wichert, Felix F. Reichel, Immanuel Philipp Seitz et al. · 2026 · Molecular Therapy Advances
  24. Systematic evaluation of BBB-penetrant AAV capsids in marmosets identifies VCAP-102 as a highly efficient brain-transducing capsid
    Yasunori Matsuzaki, Ayumu Konno, Kenji Sakamoto, Yasuo Uchida, Tetsuya Terasaki, Hirokazu Hirai · 2026 · Molecular Therapy Advances
  25. CA-IV-directed small-molecule shuttle enables targeted brain delivery of biologics
    Xiaozhe Ding, Xinhong Chen, Philip Boehm, Alba Carretero‐Cerdán, Seongmin Jang, Erin E. Sullivan, Cynthia Mary Arokiaraj, Fiona Ristic, Bill Kavvathas, Lillian Campos et al. · 2026 · Nature Chemical Biology
  26. Validation studies and multi-omics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behavior
    William B. Lynch, Sophia A. Miracle, Stanley I. Goldstein, Jacob A. Beierle, Rhea Bhandari, Ethan Gerhardt, Ava D. Farnan, Binh-Minh Nguyen, Kelly K. Wingfield, Ida Kazerani et al. · 2024 · Journal of Pharmacology and Experimental Therapeutics
  27. Next generation AAV-F capsid gene therapy rescues disease pathology in a model of pyruvate dehydrogenase complex deficiency
    Anna Keegan, Özge Çetin, Ellie M. Chilcott, Juan F. Antinao Diaz, Simon D. Eaton, Simon N. Waddington, John Robert Counsell, Shamima Rahman, Rajvinder Karda · 2026 · Molecular Therapy Advances
  28. Directed evolution of AAV capsids for improved efficacy and specificity of delivery to preclinical models of human liver
    Magdalena Kwiatek, Aleksander Michalski, Karolina Abramowicz, Paweł Rutyna, Magdalena Wasiak, M. Reichert, Leszek Lisowski · 2023 · Lekarz Wojskowy
  29. Targeted AAV Transduction for Fluorescent Imaging of the Tripartite Synapse
    Isabel N. Christie, James R. Reynolds · 2024 · Neuromethods
  30. Efficient Gene-Editing in Human Pluripotent Stem Cells Through Simplified Assembly of Adeno-Associated Viral (AAV) Donor Templates
    Berta Marcó de la Cruz, Sanhita Mitra, Binqing He, Melis Çelik, Debora Kaminski, Erik Smedler, Fredrik Sterky · 2024 · BIO-PROTOCOL
  31. Intratumoral gene delivery of 4-1BBL boosts IL-12-triggered anti-glioblastoma immunity
    Taral R. Lunavat, Lisa Nieland, Sanne M. van de Looij, Alexandra J E M de Reus, Charles Couturier, Chadi A. El Farran, Tyler E. Miller, Julia K. Lill, Maryam Schübel, Tianhe Xiao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Intra-arterial Gene Delivery for Neurodegenerative Diseases
    Jonathan M. Fischell · 2025 · Springer eBooks
  33. AAV gene therapy for Cockayne syndrome
    Ana Rita Batista, Aine C. Scholand, William S. Callahan, McKenna K. Watson, Cassandra M. Sion, Tyler Mola, Kennedy O’Hara, Oliver D. King, Robert M King, Miguel Sena‐Esteves · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  34. rAAV-Mediated Gene Therapy Targeting CNS Disorders
    Lester Suárez-Amarán, Christina A. Chatzi, Inge Flier, Richard Jude Samulski · 2025 · Springer eBooks
  35. EvoPRAISE: computationally guided directed evolution for rational AAV capsid engineering
    Hiroaki Ono, Shoko Fujino, Genshiro A. Sunagawa · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  36. VCAP-102 Achieves Exceptional BBB Penetration in Marmosets After Ten Years of AAV Capsid Evaluation
    Yasunori Matsuzaki, Ayumu Konno, Yasuo Uchida, Tetsuya Terasaki, Hirokazu Hirai · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization
    Youssef Fouani, Martin Oti, Sebastian Jarosch, Dragica Blazevic, Matthias J. Duechs, Stephanie Ketterer, Robert Becker, Sarah Abele, Benjamin Strobel, Tanja Schoenberger et al. · 2026 · Molecular Therapy Advances
  38. Astrocytic and endothelial GLUT1 restoration improves brain glucose homeostasis in GLUT1 deficiency syndrome
    Shoko Tamura, Hiroko Shimbo, N Aruga, Mai Kawaguchi, Haruo Okado, Yuga Yasuda, Yuichiro Miyaoka, Ayano Sasakura, Kinya Matsuo, Hideaki Nishihara et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants
    Hiroaki Ono, Shoko Fujino, Genshiro A. Sunagawa · 2026 · iScience
  40. Could the overexpression of neuroglobin, via an intravenous administration of an AAV2/9 vector, durably attenuate cerebellar ataxia in Harlequin mice by preserving mitochondrial homeostasis?
    Edward Ratcliffe · 2025 · theses.fr (ABES)
  41. Novel Nanotechnological Approaches for Glioblastoma Targeting
    Arianna Rinaldi · 2024 · theses.fr (ABES)
  42. Selecting Novel Retino-tropic AAV Capsids by Directed Evolution
    Adrian Westhaus, Leszek Lisowski · 2026 · Methods in molecular biology
  43. Systemic AAV8-SIL1-TAT therapy improves motor function in a mouse model of Marinesco-Sjögren syndrome
    Fabio Bellia, Anna Giulia Ruggieri, Laura Amodei, Francesca Potenza, Beatrice Dufrusine, Valeria Panella, Francesco Pizzo, Alessia Lamolinara, Manuela Iezzi, Luca Federici et al. · 2026 · Biochemical Pharmacology
  44. Trends in the Engineering of Adeno-Associated Virus (AAV) for Precision Gene Delivery to the Central Nervous System (CNS)
    Ezekiel S. Oloruntimehin, Alexander S. Malogolovkin · 2026 · International Journal of Molecular Sciences
  45. Preclinical translation of Neurofibromatosis type 1 ( NF1) exon 17 skipping using targeted U7-SnRNA packaged into engineered AAV serotypes
    Marc Moore, Kimia Rayat-Sanati, Xiaoxia Zhang, Hui Liu, Zakaria Rostamitehrani, Tarah Vijayasarathy, Erik Westin, Miguel Sena‐Esteves, Casey A. Maguire, Robert A. Kesterson et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  46. AAV-mediated gene therapy demonstrates phenotypic rescue in a mouse model of Cockayne syndrome
    Ana Rita Batista, Aine C. Scholand, William S. Callahan, McKenna K. Watson, Cassandra M. Sion, Tyler Mola, Kennedy O'Hara, Simon A. Wentworth, William S. Sena-Esteves, Oliver D. King et al. · 2026 · Journal of Clinical Investigation
  47. BI-TfR1 CapX rapidly transits the blood-brain barrier for efficient, low-dose gene delivery throughout the CNS
    Ken Y. Chan, Chin-Yen Lin, Qin Huang, Simon Pacouret, Qingxia Zheng, John W. Harvey, Pamela P. Brauer, Jencilin Johnston, Fiona E. Serack, Jessie R. Davis et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Benchmarking the next generation of brain-penetrant AAV capsids
    Vania Broccoli, Simone Alberti · 2026 · Molecular Therapy Advances